Skip to content
  • ABOUT
  • SCIENCE
  • TEAM
  • NEWS
  • CONTACT US
  • Twitter
  • Linkedin

Asgard Therapeutics awarded Vinnova’s Innovative Startup Step 2

  1. Home
  2. Uncategorized
  3. Asgard Therapeutics awarded Vinnova’s Innovative Startup Step 2
  • Posted on March 31, 2020

Swedish start-up company Asgard Therapeutics has been awarded the second step of Vinnova’s Innovative Startup program in order to further develop a new cancer immunotherapy based on dendritic cell reprogramming.

Asgard Therapeutics awarded Vinnova’s Innovative Startup Step 2
FacebookTwitterLinkedIn
Asgard Therapeutics awarded with Lund University Innovation VFT+ Funds
Previous
Filipe Pereira, co-founder of Asgard Therapeutics, awarded with a BII PreSeed grant
Next
  • ABOUT
  • SCIENCE
  • TEAM
  • NEWS
  • CONTACT US
  • Twitter
  • Linkedin
© 2021 - ASGARD THERAPEUTICS. All rights reserved.